Respiratory syncytial virus risk factors in late preterm infants. (Q53183759)

12 May 2018

title

Respiratory syncytial virus risk factors in late preterm infants. (English)

1 reference

12 May 2018

1 reference

Marcello Lanari

1

1 reference

12 May 2018

Michela Silvestri

series ordinal

2

1 reference

12 May 2018

Giovanni A Rossi

series ordinal

3

1 reference

12 May 2018

publication date

1 January 2009

1 reference

12 May 2018

Journal of Maternal-Fetal and Neonatal Medicine

published in

1 reference

12 May 2018

volume

22 Suppl 3

1 reference

12 May 2018

page(s)

102-107

1 reference

12 May 2018

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

cites work

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

The burden of respiratory syncytial virus infection in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Identifying risk factors for severe respiratory syncytial virus among infants born after 33 through 35 completed weeks of gestation: different methodologies yield consistent findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Abnormal lung function in healthy preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Reduced lung function in healthy preterm infants in the first months of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Serum immunoglobulin levels and incidence of infection during the first year of life in full-term and preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Palivizumab prophylaxis of respiratory syncytial virus disease in 2000–2001: Results from the palivizumab outcomes registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14767050903194438

10.1080/14767050903194438

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018